Clinical Trials Logo

Clinical Trial Summary

Vulvovaginal irritation due to dryness is a frequent complaint among post- and some premenopausal women. International guidelines recommend non-hormonal products as first line therapy.

Efficacy and safety of the medical device Vagisan® Moisturising Cream (VMC), a non-hormonal vaginal cream for the treatment of vulvovaginal dryness and Gynomunal Vaginal Gel (GVG), a non-hormonal gel should be compared in a 12-week multicentre, open-label, randomised, two-period cross-over phase III trial. The hypothesis was that VMC is non-inferior to GVG.

The primary endpoint was the sum of subjective symptoms of vulvovaginal atrophy (VVA) added up over each treatment period. Furthermore, objective symptoms of VVA and adverse effects were planned to be assessed. 120 women should be randomly allocated to either of the two treatments, each given over a period of 4 weeks.


Clinical Trial Description

The purpose of the study was to test the non-inferiority of the medical device Vagisan® Moisturising Cream (VMC) in comparison to Gynomunal® vaginal gel (GVG) in 6 centres in 120 women who suffered from "vaginal dryness". The main objective criterion was to compare the sum of 4 subjective symptoms of "vaginal dryness" measured daily over a period of 28 days. VMC should be applied daily, while GVG had to be administered daily during the first week and twice weekly thereafter.

The main objective parameter for efficacy analysis was the sum of the subjective symptoms of vaginal dryness (feeling of dryness, itching, burning sensation and pain) before, during (patient diaries) and after the 28-day therapy period.

The per-protocol analysis and of the intent-to-treat analysis should prove non-inferiority of VMC compared to GVG, despite a possible carry-over effect to the detriment of VMC. To avoid the problem of any possible carry-over effect the analysis of the first period was chosen for the primary comparison of both products.

Furthermore, objective symptoms of vaginal dryness detected via colposcopy, the vaginal secretion's pH, the efficacy assessment by the patients and the treating doctor and patients' questionnaires with regard to the product characteristics of the medical devices should be evaluated. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02269826
Study type Interventional
Source Dr. August Wolff GmbH & Co. KG Arzneimittel
Contact
Status Completed
Phase N/A
Start date February 2008
Completion date December 2008

See also
  Status Clinical Trial Phase
Not yet recruiting NCT01170195 - Effectiveness of Licorice Extract Dietary Supplement on the Treatment of Postmenopausal Symptoms Phase 1/Phase 2
Withdrawn NCT03666819 - Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy Phase 2
Completed NCT02937805 - Effects of a Moisturizing Cream on Vaginal and Vulvar Mucous Membranes N/A
Completed NCT02994342 - Efficacy and Tolerability Study of ZP-025 Vaginal Gel for the Treatment of Vaginal Dryness N/A
Recruiting NCT05913479 - Evaluation of the Efficacy and Safety of Mucogye® Gel as a Moisturizer N/A
Completed NCT03307044 - Fractional CO2 Laser Therapy for Survivors of Breast Malignancies N/A
Recruiting NCT03714581 - Laser Therapy Following Radiotherapy for Gynecological Cancer N/A
Completed NCT01948583 - Humectant Activity of a New Formulation of Gynomunal® Vaginalgel Phase 4
Completed NCT03178825 - Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause N/A
Completed NCT03372720 - Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors N/A
Not yet recruiting NCT06282614 - Performance and Safety of MUCOGYNE® Ovule as a Moisturizer N/A
Completed NCT02176083 - Reproductive Health Survivorship Care Plan Pilot N/A
Completed NCT04908124 - A Clinical Investigation Into the Effectiveness and Safety of Five Water Based Personal Lubricants. Phase 3
Not yet recruiting NCT05156502 - To Assess Signs and Symptoms in Women Affected by GSM After One Cycle of Pixel CO2-Alma Fractionated Laser N/A
Completed NCT02638337 - Study to Evaluate Ospemifene in Patients With Moderate to Severe Vaginal Dryness Due to Menopause Phase 3
Not yet recruiting NCT02987647 - Perception of Efficacy, Safety and Tolerability of Three Non-hormonal Intravaginal Gels and Hormone Cream Phase 4
Not yet recruiting NCT03782961 - Evaluation of Viscosity of a Vaginal Moisturizer Phase 4
Withdrawn NCT01724242 - Vaginal DHEA for Women After Breast Cancer Phase 2/Phase 3
Completed NCT01697345 - Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy Phase 0
Completed NCT05644444 - Effectiveness and Safety of a Water-based and a Silicone-based Personal Lubricants With Sensory Action N/A